T. Kuntzer

Discipline

Psychology (11) Education (4) Communication sciences (2) Economies and finances (2) Biological anthropology (2) Sociology (1) Demography (1) Architecture, space management (1)

Type

Articles (72) Reviews (11) Books and book chapters (1)

Co-author

Date

Source

Keyword

Patients (39) Patients (39) Human beings (37) Treatment (27) disease (24) disease (24) adult (20) adult (20) Muscles (18) Older people (18) gene (17) Cases (17) Cases (17) analysis (16) Case (16) Phenotype (16) Grammar, Comparative and general--Case (16) Case (16) Analysis (16) therapy (15) Therapeutics (15) Symptoms (14) Neuropathy (13) Example (12) Immunoglobulins (11) Use (11) age (10) Diagnosis (10) Methods (10) Diagnosis (10)

Documents written by T. Kuntzer (72) | is about T. Kuntzer (0)

Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
A. Vicino et al.
Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study.
P. Ripellino et al.
The emerging spectrum of fetal acetylcholine receptor antibody-related disorders (FARAD).
N.M. Allen et al. (Oct 3, 2023)
Foodborne botulism, a forgotten yet life-threatening disease: a case report.
M.D. Schaller et al.
Early-onset leukoencephalomyelopathy due to a biallelic NDUFV1 variant in a mid-forties patient.
M. Gschwind et al.
Douleurs et faiblesse de l’épaule neurologique : attitudes pratiques [Neurological shoulder pain and weakness : practical attitudes]
F. Ochsner et al. (Apr 27, 2022)
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
LWG Luijten et al. (Dec 16, 2021)
Implication of folate deficiency in CYP2U1 loss of function.
C. Pujol et al. (Nov 1, 2021)
A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases.
L.I. Pisella et al. (Oct 26, 2021)
NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.
J.M. Good et al. (May 6, 2021)
Neuropathies aiguës sévères induites par l’infection à SARS-CoV-2 [Acute severe neuropathies in the context of SARS-CoV-2 infection]
J.B. Epiney et al. (Apr 28, 2021)
Neurologie [Recent Advances in Neurology]
A. Anichini et al. (Jan 27, 2021)
Beta Electroencephalographic Oscillation Is a Potential GABAergic Biomarker of Chronic Peripheral Neuropathic Pain.
M. Teixeira et al. (2021)
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
J. Regamey et al. (Nov 2, 2020)
SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome.
A.M. Lascano et al.
Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen-specific glycopolymer.
B. Aliu et al.
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
A. Orcurto et al.
Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention.
F. Fatehi et al. (Mar 23, 2020)
Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patients.
J.P. Molenaar et al. (Feb 1, 2020)
Neurologie [Neurology 2019]
M. Perrenoud et al. (Jan 15, 2020)
Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy.
G. Van Winckel et al. (2020)
Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
C. Perraudin et al. (2020)
Peripheral neuropathy and cognitive impairment associated with a novel monoallelic HARS variant.
P. Tsouni et al.
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.
F. Martins et al.
A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
J. Ghosn et al. (Oct 22, 2018)

next